{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:30:32Z","timestamp":1793878232225,"version":"4.7.0"},"reference-count":70,"publisher":"American Association for Cancer Research (AACR)","issue":"11","license":[{"start":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:00:00Z","timestamp":1793836800000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA098258"],"award-info":[{"award-number":["P50CA098258"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30ES010126"],"award-info":[{"award-number":["P30ES010126"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32GM122741"],"award-info":[{"award-number":["T32GM122741"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008984","name":"International Anesthesia Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015366","name":"McGovern Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>CD73 is an emerging immunotherapy target that is overexpressed in many tumors and generates an adenosine-rich microenvironment to suppress antitumor immunity. In low-grade endometrial carcinoma, CD73 expression varies, and its impact on tumor immunobiology is unknown. Using two microsatellite-stable, grade 2 endometrioid endometrial carcinoma cohorts, in vitro NT5E (CD73) knockout\/knockdown, and single-cell and spatial analyses, we show that cancer cell CD73 loss promotes a dual inflammatory and immunosuppressive microenvironment. Cancer cell CD73 loss was associated with increased lymphovascular space invasion and worse recurrence-free and overall survival, whereas stromal CD73 expression did not correlate with outcomes. CD73 downregulation induced pro-inflammatory gene expression, which strongly correlated with upregulation of immunosuppressive genes, including CD274 (PD-L1), suggesting a compensatory mechanism limiting antitumor immunity. Tumors with low cancer cell CD73 exhibited higher PD-L1 expression that correlated with increased CD3+ T-cell infiltration, reflecting an immune-engaged but checkpoint-restrained microenvironment. Single-cell analyses demonstrated that NT5E+ nonimmune cells in immune-responsive clusters were three times less likely to express CD274. In clinically relevant low-grade endometrial carcinoma models, functional studies confirmed that CD73 loss promoted both pro-inflammatory and immunosuppressive programs. These results reveal a context-specific role for CD73 in shaping the immune landscape of low-grade endometrial carcinoma that is distinct from its function in other solid tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Unlike most cancers, in which CD73 drives immunosuppression via overexpression, we show that cancer cell CD73 loss promotes an inflammatory yet compensatory immunosuppressive microenvironment in low-grade endometrial carcinoma, revealing a context-specific role. CD73 loss in endometrial carcinoma therefore may be as immunologically significant as its overexpression in other cancers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-26-0167","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:43:56Z","timestamp":1792709036000},"page":"2602-2618","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer Cell CD73 Loss Promotes a Dual Inflammatory and Immunosuppressive Microenvironment in Endometrial Carcinoma"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1884-9032","authenticated-orcid":false,"given":"Hannah N.","family":"Lee","sequence":"first","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9072-948X","authenticated-orcid":false,"given":"Xingyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7322-021X","authenticated-orcid":false,"given":"Suzanne M.","family":"Crumley","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, Missouri."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4171-6836","authenticated-orcid":false,"given":"Emily M.","family":"Rabjohns","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina."},{"id":[{"id":"https:\/\/ror.org\/0130frc33","id-type":"ROR","asserted-by":"publisher"}],"name":"University of North Carolina at Chapel Hill 3 Graduate Curriculum in Pathobiology and Translational Science, , Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3498-3111","authenticated-orcid":false,"given":"Luan H.","family":"Phan","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine, University of Texas McGovern Medical School, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8331-2357","authenticated-orcid":false,"given":"Di","family":"Wu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0130frc33","id-type":"ROR","asserted-by":"publisher"}],"name":"University of North Carolina at Chapel Hill 5 Department of Biostatistics, Gillings School of Global Public Health, , Chapel Hill, North Carolina."},{"id":[{"id":"https:\/\/ror.org\/0130frc33","id-type":"ROR","asserted-by":"publisher"}],"name":"University of North Carolina at Chapel Hill 6 Department of Biomedical Sciences, Adams School of Dentistry, , Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-273X","authenticated-orcid":false,"given":"Russell R.","family":"Broaddus","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina."},{"id":[{"id":"https:\/\/ror.org\/0130frc33","id-type":"ROR","asserted-by":"publisher"}],"name":"University of North Carolina at Chapel Hill 7 UNC Lineberger Comprehensive Cancer Center, , Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3081-8685","authenticated-orcid":false,"given":"Cyrus","family":"Vaziri","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina."},{"id":[{"id":"https:\/\/ror.org\/0130frc33","id-type":"ROR","asserted-by":"publisher"}],"name":"University of North Carolina at Chapel Hill 7 UNC Lineberger Comprehensive Cancer Center, , Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0655-7769","authenticated-orcid":false,"given":"Jessica L.","family":"Bowser","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina."},{"id":[{"id":"https:\/\/ror.org\/0130frc33","id-type":"ROR","asserted-by":"publisher"}],"name":"University of North Carolina at Chapel Hill 7 UNC Lineberger Comprehensive Cancer Center, , Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,11,5]]},"reference":[{"key":"2026110506015920200_bib1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","article-title":"The adenosine pathway in immuno-oncology","volume":"17","author":"Allard","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"2026110506015920200_bib2","doi-asserted-by":"publisher","first-page":"e004089","DOI":"10.1136\/jitc-2021-004089","article-title":"Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy","volume":"10","author":"Augustin","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2026110506015920200_bib3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1172\/JCI79380","article-title":"Loss of CD73-mediated actin polymerization promotes endometrial tumor progression","volume":"126","author":"Bowser","year":"2016","journal-title":"J Clin Invest"},{"key":"2026110506015920200_bib4","first-page":"3702","article-title":"5\u2032-nucleotidase activity in prostatic carcinoma and benign prostatic hyperplasia","volume":"49","author":"Rackley","year":"1989","journal-title":"Cancer Res"},{"key":"2026110506015920200_bib5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/carcin\/bgy154","article-title":"Cell-type-specific CD73 expression is an independent prognostic factor in bladder cancer","volume":"40","author":"Koivisto","year":"2019","journal-title":"Carcinogenesis"},{"key":"2026110506015920200_bib6","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/path.6012","article-title":"The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients","volume":"258","author":"L\u00f3pez-Janeiro","year":"2022","journal-title":"J Pathol"},{"key":"2026110506015920200_bib7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41379-021-00930-7","article-title":"Prognostic implications of tumor-infiltrating T cells in early-stage endometrial cancer","volume":"35","author":"Mendiola","year":"2022","journal-title":"Mod Pathol"},{"key":"2026110506015920200_bib8","doi-asserted-by":"publisher","first-page":"e1264565","DOI":"10.1080\/2162402X.2016.1264565","article-title":"Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition","volume":"6","author":"Eggink","year":"2017","journal-title":"Oncoimmunology"},{"key":"2026110506015920200_bib9","doi-asserted-by":"publisher","first-page":"dju245","DOI":"10.1093\/jnci\/dju245","article-title":"Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma","volume":"106","author":"Liu","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2026110506015920200_bib10","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/s41379-022-01066-y","article-title":"Genomic landscape of endometrial carcinomas of no specific molecular profile","volume":"35","author":"Momeni-Boroujeni","year":"2022","journal-title":"Mod Pathol"},{"key":"2026110506015920200_bib11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"2026110506015920200_bib12","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1158\/1078-0432.CCR-16-2655","article-title":"Immune microenvironment in microsatellite-instable endometrial cancers: hereditary or sporadic origin matters","volume":"23","author":"Pakish","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2026110506015920200_bib13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ygyno.2015.01.541","article-title":"Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas","volume":"137","author":"McConechy","year":"2015","journal-title":"Gynecol Oncol"},{"key":"2026110506015920200_bib14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41379-018-0148-x","article-title":"Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes","volume":"32","author":"Crumley","year":"2019","journal-title":"Mod Pathol"},{"key":"2026110506015920200_bib15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/path.5511","article-title":"Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours","volume":"252","author":"Cochrane","year":"2020","journal-title":"J Pathol"},{"key":"2026110506015920200_bib16","doi-asserted-by":"publisher","first-page":"100791","DOI":"10.1016\/j.modpat.2025.100791","article-title":"Differential localization of beta-catenin protein in CTNNB1 mutant endometrial cancers results in distinct transcriptional profiles","volume":"38","author":"Parrish","year":"2025","journal-title":"Mod Pathol"},{"key":"2026110506015920200_bib17","doi-asserted-by":"publisher","first-page":"e189510","DOI":"10.1172\/jci.insight.189510","article-title":"CD73 restrains mutant beta-catenin oncogenic activity in endometrial carcinomas","volume":"11","author":"Hirsch","year":"2026","journal-title":"JCI Insight"},{"key":"2026110506015920200_bib18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canlet.2021.01.030","article-title":"Loss of CD73 shifts transforming growth factor-\u03b21 (TGF-\u03b21) from tumor suppressor to promoter in endometrial cancer","volume":"505","author":"Kurnit","year":"2021","journal-title":"Cancer Lett"},{"key":"2026110506015920200_bib19","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41379-018-0080-0","article-title":"Nuclear beta-catenin localization and mutation of the CTNNB1 gene: a context-dependent association","volume":"31","author":"Kim","year":"2018","journal-title":"Mod Pathol"},{"key":"2026110506015920200_bib20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.tcb.2021.05.008","article-title":"The elegant complexity of mammalian ecto-5\u2032-nucleotidase (CD73)","volume":"31","author":"Alcedo","year":"2021","journal-title":"Trends Cell Biol"},{"key":"2026110506015920200_bib21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1158\/1078-0432.CCR-15-1181","article-title":"CD73 expression is an independent prognostic factor in prostate cancer","volume":"22","author":"Leclerc","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2026110506015920200_bib22","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.3802\/jgo.2021.32.e11","article-title":"Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer","volume":"32","author":"Tortorella","year":"2021","journal-title":"J Gynecol Oncol"},{"key":"2026110506015920200_bib23","doi-asserted-by":"publisher","first-page":"595082","DOI":"10.3389\/fonc.2020.595082","article-title":"Reconstruction of immune microenvironment and signaling pathways in endometrioid endometrial adenocarcinoma during formation of lymphovascular space involvement and lymph node metastasis","volume":"10","author":"Cheng","year":"2020","journal-title":"Front Oncol"},{"key":"2026110506015920200_bib24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ni1303","article-title":"Innate immune recognition of viral infection","volume":"7","author":"Kawai","year":"2006","journal-title":"Nat Immunol"},{"key":"2026110506015920200_bib25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1189\/jlb.1102577","article-title":"Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function","volume":"74","author":"Melchjorsen","year":"2003","journal-title":"J Leukoc Biol"},{"key":"2026110506015920200_bib26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"2026110506015920200_bib27","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res"},{"key":"2026110506015920200_bib28","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-15-0255","article-title":"Classifying cancers based on T-cell infiltration and PD-L1","volume":"75","author":"Teng","year":"2015","journal-title":"Cancer Res"},{"key":"2026110506015920200_bib29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1158\/2159-8290.CD-15-0563","article-title":"Adaptive immune resistance: how cancer protects from immune attack","volume":"5","author":"Ribas","year":"2015","journal-title":"Cancer Discov"},{"key":"2026110506015920200_bib30","doi-asserted-by":"publisher","first-page":"103453","DOI":"10.1016\/j.autrev.2023.103453","article-title":"Roles of interferon induced protein with tetratricopeptide repeats (IFIT) family in autoimmune disease","volume":"22","author":"Wu","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2026110506015920200_bib31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00726-007-0612-2","article-title":"Cloning and functional characterization of the HRASLS2 gene","volume":"35","author":"Shyu","year":"2008","journal-title":"Amino Acids"},{"key":"2026110506015920200_bib32","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/modpathol.2017.15","article-title":"CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence","volume":"30","author":"Kurnit","year":"2017","journal-title":"Mod Pathol"},{"key":"2026110506015920200_bib33","doi-asserted-by":"publisher","first-page":"8520","DOI":"10.1038\/sj.onc.1207892","article-title":"DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin\/TCF pathway","volume":"23","author":"Niida","year":"2004","journal-title":"Oncogene"},{"key":"2026110506015920200_bib34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ygyno.2023.03.013","article-title":"DKK1 is a predictive biomarker for response to DKN-01: results of a phase 2 basket study in women with recurrent endometrial carcinoma","volume":"172","author":"Arend","year":"2023","journal-title":"Gynecol Oncol"},{"key":"2026110506015920200_bib35","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/s42003-022-04368-8","article-title":"Dickkopf1 fuels inflammatory cytokine responses","volume":"5","author":"Jaschke","year":"2022","journal-title":"Commun Biol"},{"key":"2026110506015920200_bib36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1084\/jem.20150950","article-title":"Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer","volume":"213","author":"D\u2019Amico","year":"2016","journal-title":"J Exp Med"},{"key":"2026110506015920200_bib37","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1158\/2326-6066.CIR-22-0218","article-title":"DKK1 promotes tumor immune evasion and impedes anti-PD-1 treatment by inducing immunosuppressive macrophages in gastric cancer","volume":"10","author":"Shi","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"2026110506015920200_bib38","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"2026110506015920200_bib39","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"},{"key":"2026110506015920200_bib40","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"key":"2026110506015920200_bib41","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1158\/2159-8290.CD-21-0506","article-title":"Endogenous retroelements and the viral mimicry response in cancer therapy and cellular homeostasis","volume":"11","author":"Chen","year":"2021","journal-title":"Cancer Discov"},{"key":"2026110506015920200_bib42","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep"},{"key":"2026110506015920200_bib43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41419-020-2546-5","article-title":"Irradiation induces cancer lung metastasis through activation of the cGAS-STING-CCL5 pathway in mesenchymal stromal cells","volume":"11","author":"Zheng","year":"2020","journal-title":"Cell Death Dis"},{"key":"2026110506015920200_bib44","doi-asserted-by":"publisher","first-page":"1108289","DOI":"10.3389\/fimmu.2023.1108289","article-title":"Understanding disruption of the gut barrier during inflammation: should we abandon traditional epithelial cell lines and switch to intestinal organoids?","volume":"14","author":"Lechuga","year":"2023","journal-title":"Front Immunol"},{"key":"2026110506015920200_bib45","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1172\/JCI15337","article-title":"Ecto-5\u2032-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia","volume":"110","author":"Synnestvedt","year":"2002","journal-title":"J Clin Invest"},{"key":"2026110506015920200_bib46","doi-asserted-by":"publisher","first-page":"1213383","DOI":"10.3389\/fcell.2023.1213383","article-title":"Analysis of the interferon-gamma-induced secretome of intestinal endothelial cells: putative impact on epithelial barrier dysfunction in IBD","volume":"11","author":"Naschberger","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"2026110506015920200_bib47","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1365-2249.2007.03439.x","article-title":"Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease","volume":"149","author":"Shioya","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"2026110506015920200_bib48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cyto.2015.10.008","article-title":"Chemokine and cytokine levels in inflammatory bowel disease patients","volume":"77","author":"Singh","year":"2016","journal-title":"Cytokine"},{"key":"2026110506015920200_bib49","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1111\/j.1572-0241.1999.01538.x","article-title":"Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn\u2019s disease","volume":"94","author":"Battaglia","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"2026110506015920200_bib50","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.1220030","article-title":"Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface","volume":"336","author":"Nancy","year":"2012","journal-title":"Science"},{"key":"2026110506015920200_bib51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.molimm.2021.09.013","article-title":"The role of IP-10 and its receptor CXCR3 in early pregnancy","volume":"140","author":"Jiang","year":"2021","journal-title":"Mol Immunol"},{"key":"2026110506015920200_bib52","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/s41423-021-00636-5","article-title":"Placenta-derived IL-32\u03b2 activates neutrophils to promote preeclampsia development","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"2026110506015920200_bib53","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/hr.2015.160","article-title":"Immune activation during the implantation phase causes preeclampsia-like symptoms via the CD40-CD40 ligand pathway in pregnant mice","volume":"39","author":"Matsubara","year":"2016","journal-title":"Hypertens Res"},{"key":"2026110506015920200_bib54","doi-asserted-by":"publisher","first-page":"596324","DOI":"10.3389\/fendo.2020.596324","article-title":"Alterations in epithelial cell polarity during endometrial receptivity: a systematic review","volume":"11","author":"Whitby","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026110506015920200_bib55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1749-6632.2010.05938.x","article-title":"Inflammation and pregnancy: the role of the immune system at the implantation site","volume":"1221","author":"Mor","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"2026110506015920200_bib56","doi-asserted-by":"publisher","first-page":"E231","DOI":"10.1073\/pnas.1206322110","article-title":"Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface","volume":"110","author":"Fu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026110506015920200_bib57","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.immuni.2018.07.017","article-title":"Interferons and proinflammatory cytokines in pregnancy and fetal development","volume":"49","author":"Yockey","year":"2018","journal-title":"Immunity"},{"key":"2026110506015920200_bib58","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.pan.2021.03.018","article-title":"Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival","volume":"21","author":"Zhao","year":"2021","journal-title":"Pancreatology"},{"key":"2026110506015920200_bib59","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00428-020-02888-4","article-title":"Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer","volume":"478","author":"Tahkola","year":"2021","journal-title":"Virchows Arch"},{"key":"2026110506015920200_bib60","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s00262-020-02820-4","article-title":"CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma","volume":"70","author":"Rocha","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"2026110506015920200_bib61","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.3892\/ol.2017.7569","article-title":"Immunohistochemical CD73 expression status in gastrointestinal neuroendocrine neoplasms: a retrospective study of 136 patients","volume":"15","author":"Ono","year":"2018","journal-title":"Oncol Lett"},{"key":"2026110506015920200_bib62","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(18)32409-7","article-title":"Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial","volume":"393","author":"Mok","year":"2019","journal-title":"Lancet"},{"key":"2026110506015920200_bib63","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"2026110506015920200_bib64","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1200\/JCO.23.00914","article-title":"First-line pembrolizumab + chemotherapy versus placebo + chemotherapy for persistent, recurrent, or metastatic cervical cancer: final overall survival results of KEYNOTE-826","volume":"41","author":"Monk","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026110506015920200_bib65","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41467-019-14060-x","article-title":"CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint","volume":"11","author":"Yu","year":"2020","journal-title":"Nat Commun"},{"key":"2026110506015920200_bib66","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/1933719112472738","article-title":"The mesenchymal-epithelial transition during in vitro decidualization","volume":"20","author":"Zhang","year":"2013","journal-title":"Reprod Sci"},{"key":"2026110506015920200_bib67","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1210\/jc.2005-0769","article-title":"Dickkopf-1, an inhibitor of Wnt signaling, is regulated by progesterone in human endometrial stromal cells","volume":"91","author":"Tulac","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2026110506015920200_bib68","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/molehr\/gar031","article-title":"Prokineticin 1 induces Dickkopf 1 expression and regulates cell proliferation and decidualization in the human endometrium","volume":"17","author":"Macdonald","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"2026110506015920200_bib69","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3389\/fimmu.2017.01840","article-title":"Interleukin-6 trans-signaling pathway promotes immunosuppressive myeloid-derived suppressor cells via suppression of suppressor of cytokine signaling 3 in breast cancer","volume":"8","author":"Jiang","year":"2017","journal-title":"Front Immunol"},{"key":"2026110506015920200_bib70","doi-asserted-by":"publisher","first-page":"215598","DOI":"10.1016\/j.canlet.2022.215598","article-title":"PMN-MDSCs accumulation induced by CXCL1 promotes CD8+ T cells exhaustion in gastric cancer","volume":"532","author":"Zhou","year":"2022","journal-title":"Cancer Lett"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-26-0167\/3841121\/crc-26-0167.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/11\/2602\/3846740\/crc-26-0167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/11\/2602\/3846740\/crc-26-0167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:02:07Z","timestamp":1793876527000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/11\/2602\/789844\/Cancer-Cell-CD73-Loss-Promotes-a-Dual-Inflammatory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,1]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-26-0167","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.34923980","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923929","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923947","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923959","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923917","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923965","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923977","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923911","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923923","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923935","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923941","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923953","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923971","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923914","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923926","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923938","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923932","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923944","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923956","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923968","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923950","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923962","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923974","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.34923920","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8820572","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11,1]]}}}